1. Home
  2. MRKR vs BLIN Comparison

MRKR vs BLIN Comparison

Compare MRKR & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • BLIN
  • Stock Information
  • Founded
  • MRKR N/A
  • BLIN 2000
  • Country
  • MRKR United States
  • BLIN United States
  • Employees
  • MRKR N/A
  • BLIN N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • BLIN EDP Services
  • Sector
  • MRKR Health Care
  • BLIN Technology
  • Exchange
  • MRKR Nasdaq
  • BLIN Nasdaq
  • Market Cap
  • MRKR 19.1M
  • BLIN 16.5M
  • IPO Year
  • MRKR N/A
  • BLIN 2007
  • Fundamental
  • Price
  • MRKR $1.71
  • BLIN $1.44
  • Analyst Decision
  • MRKR Strong Buy
  • BLIN Strong Buy
  • Analyst Count
  • MRKR 3
  • BLIN 1
  • Target Price
  • MRKR $13.17
  • BLIN $4.62
  • AVG Volume (30 Days)
  • MRKR 102.6K
  • BLIN 28.2K
  • Earning Date
  • MRKR 08-13-2025
  • BLIN 08-13-2025
  • Dividend Yield
  • MRKR N/A
  • BLIN N/A
  • EPS Growth
  • MRKR N/A
  • BLIN N/A
  • EPS
  • MRKR N/A
  • BLIN N/A
  • Revenue
  • MRKR $5,696,123.00
  • BLIN $15,465,000.00
  • Revenue This Year
  • MRKR N/A
  • BLIN $4.08
  • Revenue Next Year
  • MRKR $11.28
  • BLIN $12.95
  • P/E Ratio
  • MRKR N/A
  • BLIN N/A
  • Revenue Growth
  • MRKR 71.53
  • BLIN 1.30
  • 52 Week Low
  • MRKR $0.95
  • BLIN $0.76
  • 52 Week High
  • MRKR $5.99
  • BLIN $2.80
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 60.22
  • BLIN 42.09
  • Support Level
  • MRKR $1.56
  • BLIN $1.35
  • Resistance Level
  • MRKR $1.93
  • BLIN $1.54
  • Average True Range (ATR)
  • MRKR 0.10
  • BLIN 0.07
  • MACD
  • MRKR 0.02
  • BLIN 0.00
  • Stochastic Oscillator
  • MRKR 57.69
  • BLIN 42.86

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: